secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDEXX LABORATORIES INC /DE (IDXX)
CIK:        0000874716
Form:       8-K
Filed at:   2024-11-21T23:59:59+00:00
Accession:  0001104659-24-121326
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IDEXX CFO Brian McKeon to retire June 2025; Andrew Emerson named successor effective March 1, 2025
--------------------------------------------------------------------------------

- McKeon will retire June 1, 2025; will step down as CFO March 1, 2025 and serve as Special Advisor until retirement.
- Andrew Emerson appointed EVP, CFO and Treasurer effective March 1, 2025; previously SVP Corporate and CAG Finance.
- Emerson's compensation: base salary $550K, target bonus 75% of salary, eligible for annual equity grants, change-in-control benefits.
- McKeon oversaw significant growth; Emerson has nine years at IDEXX leading CAG finance and corporate finance since 2020.
- Company reaffirmed full-year 2024 guidance as provided on October 31, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874716/000110465924121326/0001104659-24-121326-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874716/000110465924121326/tm2429071d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-121326

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer